GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ansell Ltd (OTCPK:ANSLY) » Definitions » 12-1 Month Momentum %
中文

Ansell (Ansell) 12-1 Month Momentum % : -14.46% (As of Today)


View and export this data going back to 2007. Start your Free Trial

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-04-24), Ansell's 12-1 Month Momentum % is -14.46%.

The industry rank for Ansell's 12-1 Month Momentum % or its related term are showing as below:

ANSLY's 12-1 Month Momentum % is ranked better than
51.81% of 855 companies
in the Medical Devices & Instruments industry
Industry Median: -16.92 vs ANSLY: -14.46

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Ansell's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ansell 12-1 Month Momentum % Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Ansell's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Ansell's 12-1 Month Momentum % falls into.



Ansell  (OTCPK:ANSLY) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ansell  (OTCPK:ANSLY) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Ansell 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Ansell's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ansell (Ansell) Business Description

Traded in Other Exchanges
Address
678 Victoria Street, Level 3, Richmond, VIC, AUS, 3121
Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 60% of revenue and 70% of operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly across more than 100 countries. In fiscal 2022, Ansell earned 45% of revenue in North America, 33% from Europe, Middle East and Africa, 14% across Asia-Pacific and the remaining 8% in Latin America.

Ansell (Ansell) Headlines

From GuruFocus

Australian Ansell Expanding Into Medical Supplies

By Holmes Osborne, CFA Holmes Osborne, CFA 02-15-2017

Ansell Growing Through M&A

By Holmes Osborne, CFA Holmes Osborne, CFA 02-22-2019

PPE Manufacturer Ansell Still Trading at a Nice Valuation

By Holmes Osborne, CFA Holmes Osborne, CFA 05-19-2021